Integrated Pharma Technologies

Integrated Pharma Technologies (iPT) was a specialized service provider and subsidiary of Q Pharma, Inc., focused on the life sciences and pharmaceutical industries. The company primarily offered drug sample accountability, regulatory consulting, and compliance services, ensuring that pharmaceutical manufacturers adhered to the Prescription Drug Marketing Act (PDMA) and other federal regulations. iPT provided expertise in sample tracking, audit reports, and validation of computer systems used in regulated environments. Following the acquisition of its parent company, Q Pharma, by Telerx (a Merck & Co. subsidiary) in 2014, iPT's operations were integrated into the broader compliance and commercialization service offerings of the acquiring entities.